A detailed history of Northwest Bank & Trust CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Northwest Bank & Trust CO holds 900 shares of EXAS stock, worth $62,820. This represents 0.05% of its overall portfolio holdings.

Number of Shares
900
Previous 900 -0.0%
Holding current value
$62,820
Previous $38 Million 61.21%
% of portfolio
0.05%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$62.68 - $95.05 $56,412 - $85,545
900 New
900 $84.5 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Northwest Bank & Trust CO Portfolio

Follow Northwest Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bank & Trust CO with notifications on news.